(Q45755300)

15 December 2017

title

Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon (English)

1 reference

15 December 2017

eradication of infectious diseases

main subject

1 reference

1 reference

Fukuda M

1

1 reference

15 December 2017

Chayama K

2

1 reference

15 December 2017

Tsubota A

3

1 reference

15 December 2017

Kobayashi M

4

1 reference

15 December 2017

Hashimoto M

5

1 reference

15 December 2017

Miyano Y

6

1 reference

15 December 2017

Koike H

7

1 reference

15 December 2017

Kobayashi M

8

1 reference

15 December 2017

Koida I

9

1 reference

15 December 2017

Arase Y

10

1 reference

15 December 2017

Saitoh S

11

1 reference

15 December 2017

Murashima N

12

1 reference

15 December 2017

Ikeda K

13

1 reference

15 December 2017

Kumada H

14

1 reference

15 December 2017

publication date

1 April 1998

1 reference

15 December 2017

Journal of Gastroenterology and Hepatology

published in

1 reference

15 December 2017

volume

13

1 reference

15 December 2017

page(s)

412-418

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00656.X

10.1111/J.1440-1746.1998.TB00656.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9641307

1 reference

15 December 2017